{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T16:00:48Z","timestamp":1774454448588,"version":"3.50.1"},"reference-count":53,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Despite safety warnings, antipsychotics remain commonly prescribed to older adults, particularly those with dementia, and for off-label indications. However, little is known about how prescribing patterns vary by clinician type over time.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To examine trends in antipsychotic prescribing by clinician type among Medicare beneficiaries from 2013 to 2023.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This repeated cross-sectional study used the Medicare Part D Prescribers by Provider and Drug dataset from 2013 to 2023. Participants included Medicare beneficiaries enrolled in Medicare Part D. Analyses were performed between November 2024 and June 2025.<\/jats:p>\n <\/jats:sec>\n \n Exposure<\/jats:title>\n Prescribing clinician type, categorized as psychiatrist, primary care physician (PCP), advanced practice registered nurse (APRN) or physician assistant (PA), or other physician.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n Annual antipsychotic prescription claims, the proportion of claims by clinician type, the number of prescribing clinicians, and the mean number of claims per clinician.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n From 2013 to 2023, annual antipsychotic prescription claims decreased from 10.8 million to 7.8 million for psychiatrists (average annual percentage change [AAPC], \u22123.2% [95% CI, \u20133.7% to \u20132.7%];\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001) and from 7.4 million to 5.7 million for PCPs (AAPC, \u22122.6% [95% CI, \u20133.2% to \u20132.3%];\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001). In contrast, claims prescribed by APRNs or PAs more than tripled from 2013 to 2023, increasing from 3.1 million to 9.5 million (AAPC, 11.8% [95% CI, 10.9%-12.7%];\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001). The proportion of prescriptions decreased for psychiatrists (48.4% to 32.4%) and PCPs (33.0% to 23.8%) but increased for APRNs and PAs (13.8% to 39.6%) from 2013 to 2023. These shifts were associated primarily with the expanding number of prescribing APRNs and PAs rather than an increase in the mean number of claims per clinician. Although trends were observed in both rural and urban areas, rural areas experienced larger shifts from PCPs to APRNs and PAs, whereas urban areas experienced larger shifts from psychiatrists to APRNs and PAs.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this cross-sectional study of Medicare Part D data from 2013 to 2023, antipsychotic prescribing shifted from psychiatrists and PCPs to APRNs and PAs, reflecting growth in nonphysician prescribers. These findings suggest evolving roles in antipsychotic medication management and highlight the need for appropriate training for the full range of clinician types who prescribe these medications to Medicare enrollees.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.3410","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T15:30:45Z","timestamp":1774452645000},"page":"e263410","source":"Crossref","is-referenced-by-count":0,"title":["Shifts in Antipsychotic Prescribing by Clinician Type for Medicare Part D Beneficiaries, 2013-2023"],"prefix":"10.1001","volume":"9","author":[{"given":"Youngran","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Management, Policy and Community Health, School of Public Health, The University of Texas Health Science Center at Houston"},{"name":"Center for Health Care Data, School of Public Health, The University of Texas Health Science Center at Houston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Zhou","sequence":"additional","affiliation":[{"name":"Center for Health Care Data, School of Public Health, The University of Texas Health Science Center at Houston"},{"name":"Department of Biostatistics and Data Science, The University of Texas Health Science Center at Houston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shilei","family":"Du","sequence":"additional","affiliation":[{"name":"Center for Health Care Data, School of Public Health, The University of Texas Health Science Center at Houston"},{"name":"Department of Biostatistics and Data Science, The University of Texas Health Science Center at Houston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trudy M.","family":"Krause","sequence":"additional","affiliation":[{"name":"Department of Management, Policy and Community Health, School of Public Health, The University of Texas Health Science Center at Houston"},{"name":"Center for Health Care Data, School of Public Health, The University of Texas Health Science Center at Houston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Samper-Ternent","sequence":"additional","affiliation":[{"name":"Department of Management, Policy and Community Health, School of Public Health, The University of Texas Health Science Center at Houston"},{"name":"Institute of Aging, The University of Texas Health Science Center at Houston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio L.","family":"Teixeira","sequence":"additional","affiliation":[{"name":"The Glenn Biggs Institute for Alzheimer\u2019s & Neurodegenerative Diseases, The University of Texas Health Science Center at San Antonio"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","published-online":{"date-parts":[[2026,3,25]]},"reference":[{"issue":"10","key":"zoi260137r1","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.4088\/JCP.15m09863","article-title":"Antipsychotic treatment of adults in the United States.","volume":"76","author":"Olfson","year":"2015","journal-title":"J Clin Psychiatry"},{"issue":"12","key":"zoi260137r2","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1001\/jamaneurol.2023.3810","article-title":"Brexpiprazole for the treatment of agitation in Alzheimer dementia: a randomized clinical trial.","volume":"80","author":"Lee","year":"2023","journal-title":"JAMA Neurol"},{"issue":"10","key":"zoi260137r3","doi-asserted-by":"publisher","first-page":"682","DOI":"10.2174\/0115672050287534240215052417","article-title":"Antipsychotics in Alzheimer\u2019s disease: current status and therapeutic alternatives.","volume":"20","author":"Maziero","year":"2023","journal-title":"Curr Alzheimer Res"},{"issue":"12","key":"zoi260137r4","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1093\/gerona\/glz045","article-title":"Association between antipsychotics and all-cause mortality among community-dwelling older adults.","volume":"74","author":"Kheirbek","year":"2019","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"12","key":"zoi260137r5","article-title":"Antipsychotics for agitation and psychosis in people with Alzheimer\u2019s disease and vascular dementia.","volume":"12","author":"M\u00fchlbauer","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"zoi260137r6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-076268","article-title":"Multiple adverse outcomes associated with antipsychotic use in people with dementia: population based matched cohort study.","volume":"385","author":"Mok","year":"2024","journal-title":"BMJ"},{"issue":"4","key":"zoi260137r7","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.3630","article-title":"Association of the US Food and Drug Administration antipsychotic drug boxed warning with medication use and health outcomes in elderly patients with dementia.","volume":"3","author":"Rubino","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"3","key":"zoi260137r8","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1177\/0706743716673321","article-title":"Antipsychotic use in dementia.","volume":"62","author":"Kirkham","year":"2017","journal-title":"Can J Psychiatry"},{"issue":"3","key":"zoi260137r9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2024.105463","article-title":"Antipsychotic use in older adults with dementia: community and nursing facility trends in Texas, 2015-2020.","volume":"26","author":"Kim","year":"2025","journal-title":"J Am Med Dir Assoc"},{"issue":"7","key":"zoi260137r11","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1377\/hlthaff.2016.1439","article-title":"CMS strategies to reduce antipsychotic drug use in nursing home patients with dementia show some progress.","volume":"36","author":"Lucas","year":"2017","journal-title":"Health Aff (Millwood)"},{"issue":"9","key":"zoi260137r12","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1176\/ps.2009.60.9.1167","article-title":"Datapoints: psychotropic drug prescriptions by medical specialty.","volume":"60","author":"Mark","year":"2009","journal-title":"Psychiatr Serv"},{"issue":"5","key":"zoi260137r13","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1176\/appi.ps.20230156","article-title":"Psychotropic medication prescribing across medical providers, 2016-2019.","volume":"75","author":"Hughes","year":"2024","journal-title":"Psychiatr Serv"},{"issue":"3","key":"zoi260137r14","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1080\/10401230591002084","article-title":"U.S. national trends in the use of antipsychotics during office visits, 1998-2002.","volume":"17","author":"Aparasu","year":"2005","journal-title":"Ann Clin Psychiatry"},{"issue":"4","key":"zoi260137r15","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/jrh.12504","article-title":"Comparing the health workforce provider mix and the distance travelled for mental health services by rural and urban Medicare beneficiaries.","volume":"37","author":"Andrilla","year":"2021","journal-title":"J Rural Health"},{"issue":"2","key":"zoi260137r16","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.58160","article-title":"Trends in psychiatrist-led care for Medicare Part B enrollees.","volume":"8","author":"Havlik","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"9","key":"zoi260137r18","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1377\/hlthaff.2022.00289","article-title":"Trends in mental health care delivery by psychiatrists and nurse practitioners in Medicare, 2011-19.","volume":"41","author":"Cai","year":"2022","journal-title":"Health Aff (Millwood)"},{"issue":"9","key":"zoi260137r20","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1176\/appi.ps.201600405","article-title":"Psychiatric mental health nursing advanced practice workforce: capacity to address shortages of mental health professionals.","volume":"68","author":"Delaney","year":"2017","journal-title":"Psychiatr Serv"},{"issue":"6","key":"zoi260137r21","doi-asserted-by":"publisher","DOI":"10.1016\/j.outlook.2025.102523","article-title":"Medicare Part B reimbursement and service volume differences between ambulatory nurse practitioners and physicians.","volume":"73","author":"Lee","year":"2025","journal-title":"Nurs Outlook"},{"issue":"1","key":"zoi260137r22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/hec.4438","article-title":"The effect of nurse practitioner scope of practice laws on primary care delivery.","volume":"31","author":"Smith","year":"2022","journal-title":"Health Econ"},{"issue":"4","key":"zoi260137r23","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1007\/s11414-024-09889-0","article-title":"Descriptive trends in Medicaid antipsychotic prescription claims and expenditures, 2016\u20132021.","volume":"51","author":"Giron","year":"2024","journal-title":"J Behav Health Serv Res"},{"issue":"7","key":"zoi260137r24","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1176\/appi.ps.201400042","article-title":"Forecasting Medicaid expenditures for antipsychotic medications.","volume":"66","author":"Slade","year":"2015","journal-title":"Psychiatr Serv"},{"issue":"6","key":"zoi260137r25","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.sapharm.2019.08.031","article-title":"Impact of U.S. federal and state generic drug policies on drug use, spending, and patient outcomes: a systematic review.","volume":"16","author":"Mishuk","year":"2020","journal-title":"Res Social Adm Pharm"},{"issue":"3","key":"zoi260137r26","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1377\/hlthaff.2023.00999","article-title":"Medicare Part D plans greatly increased utilization restrictions on prescription drugs, 2011-20.","volume":"43","author":"Joyce","year":"2024","journal-title":"Health Aff (Millwood)"},{"issue":"7","key":"zoi260137r27","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1111\/bcp.14232","article-title":"Off-label use of quetiapine in nursing homes: does medical specialty of prescribing physicians play a role?","volume":"86","author":"M\u00fcller","year":"2020","journal-title":"Br J Clin Pharmacol"},{"issue":"7","key":"zoi260137r28","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.sapharm.2017.08.001","article-title":"Influencers of generic drug utilization: a systematic review.","volume":"14","author":"Howard","year":"2018","journal-title":"Res Social Adm Pharm"},{"issue":"7624","key":"zoi260137r35","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"335","author":"von Elm","year":"2007","journal-title":"BMJ"},{"issue":"7","key":"zoi260137r37","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1093\/pm\/pnz344","article-title":"Opioid prescribing to Medicare Part D enrollees, 2013-2017: shifting responsibility to pain management providers.","volume":"21","author":"Romman","year":"2020","journal-title":"Pain Med"},{"issue":"2","key":"zoi260137r40","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1177\/10775587231211966","article-title":"Prescribing by physician associates and nurse practitioners in older adults is outpacing traditional prescribers: implications for practice in American medicine.","volume":"81","author":"Hooker","year":"2024","journal-title":"Med Care Res Rev"},{"issue":"4","key":"zoi260137r41","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1001\/jamapsychiatry.2023.5045","article-title":"Trends in incident prescriptions for behavioral health medications in the US, 2018-2022.","volume":"81","author":"Chai","year":"2024","journal-title":"JAMA Psychiatry"},{"key":"zoi260137r42","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.genhosppsych.2023.05.012","article-title":"Low availability, long wait times, and high geographic disparity of psychiatric outpatient care in the US.","volume":"84","author":"Sun","year":"2023","journal-title":"Gen Hosp Psychiatry"},{"issue":"6","key":"zoi260137r44","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1176\/appi.ps.201700344","article-title":"Projected workforce of psychiatrists in the United States: a population analysis.","volume":"69","author":"Satiani","year":"2018","journal-title":"Psychiatr Serv"},{"issue":"4","key":"zoi260137r46","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1007\/s11606-016-3967-9","article-title":"Closing the false divide: sustainable approaches to integrating mental health services into primary care.","volume":"32","author":"Kroenke","year":"2017","journal-title":"J Gen Intern Med"},{"issue":"4","key":"zoi260137r47","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1215\/03616878-3620821","article-title":"The rise of primary care physicians in the provision of US mental health care.","volume":"41","author":"Olfson","year":"2016","journal-title":"J Health Polit Policy Law"},{"issue":"1","key":"zoi260137r49","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1176\/ps.2008.59.1.109","article-title":"Employment of advanced-practice psychiatric nurses to stem rural mental health workforce shortages.","volume":"59","author":"Hanrahan","year":"2008","journal-title":"Psychiatr Serv"},{"issue":"10","key":"zoi260137r50","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1176\/appi.ps.201600495","article-title":"Nurse practitioner independent practice authority and mental health service delivery in U.S. community health centers.","volume":"68","author":"Yang","year":"2017","journal-title":"Psychiatr Serv"},{"issue":"12","key":"zoi260137r51","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1016\/j.jamda.2021.06.019","article-title":"Growth of physicians and nurse practitioners practicing full time in nursing homes.","volume":"22","author":"Goodwin","year":"2021","journal-title":"J Am Med Dir Assoc"},{"key":"zoi260137r10","unstructured":"Medicare atypical antipsychotic drug claims for elderly nursing home residents. Office of Inspector General, Department of Health and Human Services. May 2011. Accessed June 24, 2025. https:\/\/oig.hhs.gov\/documents\/evaluation\/3016\/OEI-07-08-00150-Complete%20Report.pdf"},{"key":"zoi260137r17","unstructured":"National Academies of Sciences, Engineering, and Medicine. Behavioral health needs in the United States. In: Expanding Behavioral Health Care Workforce Participation in Medicare, Medicaid, and Marketplace Plans. The National Academies Press; 2024. Accessed August 18, 2025. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK609444\/"},{"key":"zoi260137r19","unstructured":"Institute of Medicine. The Future of Nursing: Leading Change, Advancing Health. The National Academies Press; 2011. Accessed January 11, 2026. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK209880\/"},{"key":"zoi260137r29","unstructured":"Total number of Medicare beneficiaries by type of coverage. KFF. Accessed August 13, 2025. https:\/\/www.kff.org\/medicare\/state-indicator\/total-medicare-beneficiaries\/"},{"key":"zoi260137r30","unstructured":"Medicare\u2019s mental health coverage: what\u2019s included, what\u2019s changed, and what gaps remain. The Commonwealth Fund. March 2, 2023. Accessed February 4, 2026. https:\/\/www.commonwealthfund.org\/publications\/explainer\/2023\/mar\/medicare-mental-health-coverage-included-changed-gaps-remain"},{"key":"zoi260137r31","unstructured":"Annual statistical report on the Social Security Disability Insurance Program, 2024. Social Security Administration. December 2025. Accessed January 16, 2026. https:\/\/www.ssa.gov\/policy\/docs\/statcomps\/di_asr\/index.html"},{"key":"zoi260137r32","unstructured":"Medicare Part D prescribers\u2014by provider and drug. Centers for Medicare & Medicaid Services. Published online April 8, 2025. Accessed June 6, 2025. https:\/\/data.cms.gov\/provider-summary-by-type-of-service\/medicare-part-d-prescribers\/medicare-part-d-prescribers-by-provider-and-drug"},{"key":"zoi260137r33","unstructured":"Medicare monthly enrollment. Centers for Medicare & Medicaid Services. Accessed August 13, 2025. https:\/\/data.cms.gov\/summary-statistics-on-beneficiary-enrollment\/medicare-and-medicaid-reports\/medicare-monthly-enrollment\/data"},{"key":"zoi260137r34","unstructured":"Medicare Part D prescribers methodology. Centers for Medicare & Medicaid Services. Accessed July 30, 2025. https:\/\/data.cms.gov\/resources\/medicare-part-d-prescribers-methodology"},{"key":"zoi260137r36","unstructured":"Medicare Part D prescriber PUF drug list summary, calendar years 2013-2023. Centers for Medicare & Medicaid Services. 2025. Accessed June 2, 2025. https:\/\/data.cms.gov\/sites\/default\/files\/2025-04\/MUP_DPR_RY25_P06_V10_DYT23_DLSum.xlsx"},{"key":"zoi260137r38","unstructured":"Rural Urban Commuting Area Codes data. Rural Heath Research Center. Accessed November 30, 2024. https:\/\/depts.washington.edu\/uwruca\/ruca-uses.php"},{"key":"zoi260137r39","unstructured":"Joinpoint trend analysis software. Surveillance Research Program, National Cancer Institute. Published online April 2025. Accessed June 24, 2025. https:\/\/surveillance.cancer.gov\/joinpoint"},{"key":"zoi260137r43","unstructured":"Behavioral health workforce projections, 2017-2030. Health Resources and Services Administration. Accessed September 11, 2025. https:\/\/bhw.hrsa.gov\/sites\/default\/files\/bureau-health-workforce\/data-research\/bh-workforce-projections-fact-sheet.pdf"},{"key":"zoi260137r45","unstructured":"Cottrill? A, Ochieng? N, Neuman? T. How many physicians have opted out of the Medicare program? KFF. January 17, 2025. Accessed August 13, 2025. https:\/\/www.kff.org\/other\/issue-brief\/how-many-physicians-have-opted-out-of-the-medicare-program\/"},{"key":"zoi260137r48","unstructured":"Mapping supply of the US psychiatric workforce. Health Workforce Technical Assistance Center. Accessed June 27, 2025. https:\/\/www.healthworkforceta.org\/research-alerts\/mapping-supply-of-the-us-psychiatric-workforce\/"},{"key":"zoi260137r52","unstructured":"Physician assistant practice and prescriptive authority\u2014scope of practice policy. National Conference of State Legislatures. Accessed August 14, 2025. https:\/\/www.ncsl.org\/scope-of-practice-policy\/practitioners\/physician-assistants\/physician-assistant-practice-and-prescriptive-authority"},{"key":"zoi260137r53","unstructured":"Nurse practitioner practice and prescriptive authority\u2014scope of practice policy. National Conference of State Legislatures. Accessed August 14, 2025. https:\/\/www.ncsl.org\/scope-of-practice-policy\/practitioners\/advanced-practice-registered-nurses\/nurse-practitioner-practice-and-prescriptive-authority"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2846940\/kim_2026_oi_260137_1773848828.17716.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T15:30:55Z","timestamp":1774452655000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2846940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,25]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.3410","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,25]]}}}